Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Mean serum 25(OH)D concentrations were 39.4±20.2 nmol/l in the OP group and 44.1±20.6 nmol/l in the control group, with no statistically significant difference between the groups (p=0.47); both groups exhibited values below the reference range (75 to 250 nmol/l).

Source: Baseline examination. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A single-center cross-sectional observational study was approved by the Ethics Committee of University Hospital Hradec Kralove (No.

Source: Methods.

The study included postmenopausal women and men aged 49 to 88 years (mean ± SD: 70.4±7.8 years) who underwent total hip arthroplasty.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Expression of Senescence and Osteoporosis-Associated microRNAs in Human Bone and Their Correlations With Clinical Parameters of Osteoporotic Patients

Observational study · Physiological Research · 2026

Original publication title

Expression of Senescence and Osteoporosis-Associated microRNAs in Human Bone and Their Correlations With Clinical Parameters of Osteoporotic Patients

Kveta VRABLIKOVA; Petr HOZA; Helena PAROVA; Marian RYBAR; Japneet KAUR; Sundeep KHOSLA; David MONROE; Petra SAUER MYKISKOVA; Vladimir PALICKA

© 2026 by the authors

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Summary

Osteoporosis is an age-related disease associated with impaired bone remodeling and cellular senescence. MicroRNAs (miRNAs) play an important regulatory role in these processes. This study aimed to identify senescence-associated miRNAs in human osteoporotic bone tissue and to assess their relationship with clinical parameters. A total of 46 patients undergoing total hip arthroplasty were included in this single-center cross-sectional study, representing a relatively large and unique cohort of human bone tissue samples: 21 with osteoporotic proximal femur fracture and 25 with elective arthroplasty for osteoarthritis as controls.

Total RNA was isolated from femoral neck biopsies, and the relative expression of 11 selected miRNAs was quantified by qRT-PCR and expressed using 2^−ΔΔCt method. Data were analyzed using t-tests, correlation analysis, and generalized linear models (GLM). MiR-106a-5p was significantly upregulated in osteoporotic patients, whereas miR-34a-5p, miR-218-5p, and miR-155-5p were significantly downregulated. After adjustment for clinical variables, miR-106a-5p remained independently positively associated with osteoporosis, while miR-34a-5p and miR-218-5p showed independent negative associations. MiR-92a-3p and miR-181a-5p became significantly associated with osteoporosis only after adjustment.

Network analysis linked the dysregulated miRNAs to genes involved in DNA damage response and cell-cycle control. Osteoporosis is associated with a specific senescence-related miRNA signature in human bone tissue. Integration of molecular and clinical data improved the interpretation of miRNA-disease associations and supports the potential of selected miRNAs as biomarkers of bone aging and osteoporosis.

Authors’ abstract

Summary

Osteoporosis is an age-related disease associated with impaired bone remodeling and cellular senescence. MicroRNAs (miRNAs) play an important regulatory role in these processes. This study aimed to identify senescence-associated miRNAs in human osteoporotic bone tissue and to assess their relationship with clinical parameters. A total of 46 patients undergoing total hip arthroplasty were included in this single-center cross-sectional study, representing a relatively large and unique cohort of human bone tissue samples: 21 with osteoporotic proximal femur fracture and 25 with elective arthroplasty for osteoarthritis as controls.

Total RNA was isolated from femoral neck biopsies, and the relative expression of 11 selected miRNAs was quantified by qRT-PCR and expressed using 2^−ΔΔCt method. Data were analyzed using t-tests, correlation analysis, and generalized linear models (GLM). MiR-106a-5p was significantly upregulated in osteoporotic patients, whereas miR-34a-5p, miR-218-5p, and miR-155-5p were significantly downregulated. After adjustment for clinical variables, miR-106a-5p remained independently positively associated with osteoporosis, while miR-34a-5p and miR-218-5p showed independent negative associations. MiR-92a-3p and miR-181a-5p became significantly associated with osteoporosis only after adjustment.

Network analysis linked the dysregulated miRNAs to genes involved in DNA damage response and cell-cycle control. Osteoporosis is associated with a specific senescence-related miRNA signature in human bone tissue. Integration of molecular and clinical data improved the interpretation of miRNA-disease associations and supports the potential of selected miRNAs as biomarkers of bone aging and osteoporosis.

Publication and source details

Original title: Expression of Senescence and Osteoporosis-Associated microRNAs in Human Bone and Their Correlations With Clinical Parameters of Osteoporotic Patients

Kveta VRABLIKOVA; Petr HOZA; Helena PAROVA; Marian RYBAR; Japneet KAUR; Sundeep KHOSLA; David MONROE; Petra SAUER MYKISKOVA; Vladimir PALICKA

Physiological Research · 2026

Corresponding author: K. Vrablikova, Department of Clinical Biochemistry, University Hospital Hradec Kralove, Faculty of Medicine Charles University in Hradec Kralove, Sokolska 581, 500 05 Czech Republic. E-mail: vrablikovakveta@gmail.com© 2026 by the authors2026https://creativecommons.org/licenses/by/4.0/An open access article under the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/Cooperatio Program, research area DIAG, and MH CZ: DROUHHK, 00179906

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:11:41.049102+00:00

DOI: 10.33549/physiolres.935778 · PMC13557538